Cargando…
Topical Insights Into the Post-Approval Controversies of Aducanumab
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637044/ https://www.ncbi.nlm.nih.gov/pubmed/34867420 http://dx.doi.org/10.3389/fphar.2021.787303 |
| _version_ | 1784608663124574208 |
|---|---|
| author | Kumar, Dhiraj Yadav, Dharmendra Kumar Hassan, Md Imtaiyaz |
| author_facet | Kumar, Dhiraj Yadav, Dharmendra Kumar Hassan, Md Imtaiyaz |
| author_sort | Kumar, Dhiraj |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8637044 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86370442021-12-03 Topical Insights Into the Post-Approval Controversies of Aducanumab Kumar, Dhiraj Yadav, Dharmendra Kumar Hassan, Md Imtaiyaz Front Pharmacol Pharmacology Frontiers Media S.A. 2021-11-18 /pmc/articles/PMC8637044/ /pubmed/34867420 http://dx.doi.org/10.3389/fphar.2021.787303 Text en Copyright © 2021 Kumar, Yadav and Hassan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Kumar, Dhiraj Yadav, Dharmendra Kumar Hassan, Md Imtaiyaz Topical Insights Into the Post-Approval Controversies of Aducanumab |
| title | Topical Insights Into the Post-Approval Controversies of Aducanumab |
| title_full | Topical Insights Into the Post-Approval Controversies of Aducanumab |
| title_fullStr | Topical Insights Into the Post-Approval Controversies of Aducanumab |
| title_full_unstemmed | Topical Insights Into the Post-Approval Controversies of Aducanumab |
| title_short | Topical Insights Into the Post-Approval Controversies of Aducanumab |
| title_sort | topical insights into the post-approval controversies of aducanumab |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637044/ https://www.ncbi.nlm.nih.gov/pubmed/34867420 http://dx.doi.org/10.3389/fphar.2021.787303 |
| work_keys_str_mv | AT kumardhiraj topicalinsightsintothepostapprovalcontroversiesofaducanumab AT yadavdharmendrakumar topicalinsightsintothepostapprovalcontroversiesofaducanumab AT hassanmdimtaiyaz topicalinsightsintothepostapprovalcontroversiesofaducanumab |